The current valuation score of Citius Pharmaceuticals Inc is 8.71, ranking 94 out of 386 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.24, which is -98.09% below the recent high of -0.00 and -3139.06% above the recent low of -7.79.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.